[Clinicopathological features and outcomes: analysis of 21 cases of lymphoma in pregnancy]. 2015

Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
Department of Medical Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,Beijing 100021, China.

OBJECTIVE To evaluate the clinicopathological features and outcomes of lymphoma in pregnancy. METHODS A total of 21 patients with lymphoma in pregnancy were diagnosed and treated at our hospital between January 1999 and January 2012. The clinicopathological data were analyzed retrospectively. RESULTS There were 11 cases of Hodgkin's lymphoma (HL) and 10 cases of nodular sclerosis classical Hodgkin's lymphoma (NSCHL). And, among 10 cases of non-Hodgkin's lymphomas (NHL), there were diffuse large B cell lymphoma (n = 6),B-cell lymphoma, non-classifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma (n = 1), small lymphocytic lymphoma (n = 1), anaplastic large cell lymphoma with anaplastic lymphoma kinase (ALK) positive (n = 1) and T-cell lymphoblastic lymphoma (n = 1). The median age was 26(22-35) years.Superficial lymphadenopathy was more common in HL than in NHL (10/11 vs 3/10, P = 0.008). At diagnosis, bulky disease and extranodal involvement were more prevalent in NHL than in HL (8/10 vs 2/11, P = 0.009; 7/10 vs 2/11, P = 0.030). All patients received chemotherapy and those with early stages also had combined radiotherapy. Ten patients with HL and 6 patients with NHL achieved complete remission. During a median follow-up of 90 months for HL, the 5-year progression-free survival (PFS) and overall survival (OS) rates were 87.5% and 100% respectively. And during a median follow-up of 31 months for NHL, the 2-year PFS and OS rates were 66.7% and 77.8% respectively. The values of PFS and OS of NHL were inferior to those of HL (P = 0.073 and P = 0.066 respectively).One case of HL and 1 case of NHL received chemotherapy in the second trimester. The patients and their children experienced good outcomes. CONCLUSIONS NSCHL is the most prevalent subtype of HL during pregnancy. B cell lymphoma and aggressive subtypes are most common for NHL during pregnancy. The outcomes of NHL are inferior to those of HL during pregnancy.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011252 Pregnancy Complications, Neoplastic The co-occurrence of pregnancy and NEOPLASMS. The neoplastic disease may precede or follow FERTILIZATION. Complications, Neoplastic Pregnancy,Neoplastic Pregnancy Complications,Pregnancy, Neoplastic Complications,Complication, Neoplastic Pregnancy,Neoplastic Pregnancy Complication,Pregnancies, Neoplastic Complications,Pregnancy Complication, Neoplastic
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
January 2002, Pathology, research and practice,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
January 2007, Zhonghua yi xue za zhi,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
October 2020, Zhonghua yi xue za zhi,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
January 2019, Ophthalmic plastic and reconstructive surgery,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
October 1998, Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
September 2013, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
April 2022, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
December 1982, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
June 2022, Leukemia research,
Lin Gui, and Yuankai Shi, and Xiaohui He, and Liqiang Zhou, and Mei Dong, and Shengyu Zhou, and Peng Yuan, and Peng Liu, and Jianliang Yang, and Changgong Zhang, and Yan Qin, and Sheng Yang
November 2004, Pathology international,
Copied contents to your clipboard!